可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]胡大一. 心血管疾病防治中国专家共识[M]. 北京: 中国环境科学出版社, 2006:103-110.
[2]史旭波,胡大一. 血小板予抗血小板治疗[J]. 临床荟萃, 2008, 23(4):229-231.
[3]Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study[J]. J Am Coll Cardiol, 2005, 46(10):1820-1826.
[4] Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patientswith acute myocardial infarction[J]. Circulation, 2004, 109(25):3171-3175.
[5]Moussa I, Dimard C, remers B, et al. Subacute stent thrombosis in the era of interavascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors,and clinical outcome[J]. J Am Coll Cardiol, 1997, 29(1):6-12.
[6] Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans[J]. Circulation, 2003, 108(14):1701-1706.
[7]Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study[J]. Lancet, 2001, 358(9281):527-533.
[8] Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial[J]. JAMA, 2002, 288(19):2411-2420.
[9]Cattaneo M. Aspirin and clopidogrel: Efficacy, safety, and the Issue of drug resistance J[J]. Arterioscler Thromb Vasc Biol, 2004, 24(11):1980-1987.
[10]Michelson AD. Platelet function testing in cardiovascular diseases[J]. Circulation, 2004, 110(19):e489-e493.
[11]Hobson AR, Petley GW, Dawkins KD, et al. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography[J]. Platelets, 2007, 18(7):497-505.
[12]Bliden KP, DiChiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention:is the current antiplatelet therapy adequate?[J]. J Am Coll Cardiol, 2007, 49(6):657-666.
[13]Mak KH, Belli G, Ellis SG, et al. Subacute stent thrombosis: evolviong essues and current concepts[J]. J Am Coll Cardiol, 1996, 27(2):494-503.